Cite

    Joseph Fiore et al.. “Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance.” Therapeutic advances in vaccines and immunotherapy, vol. 9, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100138935763.0x000024